Johan Aurelius

Goeteborg, O, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Experience and Perception of Patients and Healthcare Professionals on Acute Leukemia in Rwanda: A Qualitative Study.

Experience and Perception of Patients and Healthcare Professionals on Acute Leukemia in Rwanda: A Qualitative Study.

Journal: Cancer management and research

Published: February 23, 2022

Idelalisib Rescues Natural Killer Cells from Monocyte-Induced Immunosuppression by Inhibiting NOX2-Derived Reactive Oxygen Species.

Idelalisib Rescues Natural Killer Cells from Monocyte-Induced Immunosuppression by Inhibiting NOX2-Derived Reactive Oxygen Species.

Journal: Cancer immunology research

Published: January 30, 2020

IFNL4 Genotypes Predict Clearance of RNA Viruses in Rwandan Children With Upper Respiratory Tract Infections.

IFNL4 Genotypes Predict Clearance of RNA Viruses in Rwandan Children With Upper Respiratory Tract Infections.

Journal: Frontiers in cellular and infection microbiology

Published: July 03, 2019

Anthracycline-based consolidation may determine outcome of post-consolidation immunotherapy in AML.

Anthracycline-based consolidation may determine outcome of post-consolidation immunotherapy in AML.

Journal: Leukemia & lymphoma

Published: April 18, 2019

The HLA-B -21 dimorphism impacts on NK cell education and clinical outcome of immunotherapy in acute myeloid leukemia.

The HLA-B -21 dimorphism impacts on NK cell education and clinical outcome of immunotherapy in acute myeloid leukemia.

Journal: Blood

Published: September 13, 2018

Anti-Leukemic Properties of Histamine in Monocytic Leukemia: The Role of NOX2.

Anti-Leukemic Properties of Histamine in Monocytic Leukemia: The Role of NOX2.

Journal: Frontiers in oncology

Published: March 19, 2018

Cytomegalovirus Serostatus Affects Autoreactive NK Cells and Outcomes of IL2-Based Immunotherapy in Acute Myeloid Leukemia.

Cytomegalovirus Serostatus Affects Autoreactive NK Cells and Outcomes of IL2-Based Immunotherapy in Acute Myeloid Leukemia.

Journal: Cancer immunology research

Published: December 11, 2017

Impact of killer-immunoglobulin-like receptor and human leukocyte antigen genotypes on the efficacy of immunotherapy in acute myeloid leukemia.

Impact of killer-immunoglobulin-like receptor and human leukocyte antigen genotypes on the efficacy of immunotherapy in acute myeloid leukemia.

Journal: Leukemia

Published: March 01, 2017

Role of regulatory T cells in acute myeloid leukemia patients undergoing relapse-preventive immunotherapy.

Role of regulatory T cells in acute myeloid leukemia patients undergoing relapse-preventive immunotherapy.

Journal: Cancer immunology, immunotherapy : CII

Published: January 02, 2017

Dynamics of myeloid cell populations during relapse-preventive immunotherapy in acute myeloid leukemia.

Dynamics of myeloid cell populations during relapse-preventive immunotherapy in acute myeloid leukemia.

Journal: Journal of leukocyte biology

Published: November 01, 2016

NOX2-dependent immunosuppression in chronic myelomonocytic leukemia.

NOX2-dependent immunosuppression in chronic myelomonocytic leukemia.

Journal: Journal of leukocyte biology

Published: November 01, 2016

Reactive oxygen species induced by therapeutic CD20 antibodies inhibit natural killer cell-mediated antibody-dependent cellular cytotoxicity against primary CLL cells.

Reactive oxygen species induced by therapeutic CD20 antibodies inhibit natural killer cell-mediated antibody-dependent cellular cytotoxicity against primary CLL cells.

Journal: Oncotarget

Published: March 31, 2016

Showing 1-12 of 26

Last Updated: 09/26/2026